130,537 research outputs found

    Etude de la réception d'une oeuvre littéraire (Jean Forton, écrivain oublié ?)

    No full text
    Pourquoi Jean Forton (1930-1982), romancier français publié par Gallimard de 1954 à 1966, salué par la critique de l époque et candidat au Goncourt à plusieurs reprises, est-il tombé dans un oubli quasi-complet ? Pour répondre à cette question, nous avons étudié l évolution de la réception de son œuvre de 1951 à nos jours, à travers la presse régionale et nationale, afin de clarifier le rôle des événements, des critiques et du contexte littéraire. Au travers de la destinée éditoriale de Forton, nous avons cherché à savoir si le fait de vivre en province pouvait avoir des incidences sur la notoriété d un auteur. Enfin, nous avons formulé des hypothèses sur la réception future de l'œuvre de Jean Forton, en prenant en compte les bouleversements récents et actuels du monde de l édition, la place de plus en plus restreinte de la littérature française dans le monde, ainsi que les changements d attitude dans la lecture.Why has Jean Forton a French novelist published by Gallimard from 1954 to 1966, hailed by the critics of the time and a one-time Goncourt Prize runner fallen into near-oblivion ? To answer this question, we have examined the evolution of the way his works have been received from 1951 to this day, through both the national and regional press, with a view to clarifying the influence of events, critiques and literary context. By examining Forton s varied editorial fortunes, we try to determine whether the fact of living in the provinces has an effect on the fame of an author. The last part of our dissertation deals with a number of hypotheses concerning the future reception of Jean Forton s works. We take into account the recent and current upheavals within the world of publishing, the increasingly confined status accorded to French literature worldwide, as well as the changes in readers attitudes to literature.LE MANS-BU Lettres (721812108) / SudocSudocFranceF

    MeSH term explosion and author rank improve expert recommendations

    No full text
    Information overload is an often-cited phenomenon that reduces the productivity, efficiency and efficacy of scientists. One challenge for scientists is to find appropriate collaborators in their research. The literature describes various solutions to the problem of expertise location, but most current approaches do not appear to be very suitable for expert recommendations in biomedical research. In this study, we present the development and initial evaluation of a vector space model-based algorithm to calculate researcher similarity using four inputs: 1) MeSH terms of publications; 2) MeSH terms and author rank; 3) exploded MeSH terms; and 4) exploded MeSH terms and author rank. We developed and evaluated the algorithm using a data set of 17,525 authors and their 22,542 papers. On average, our algorithms correctly predicted 2.5 of the top 5/10 coauthors of individual scientists. Exploded MeSH and author rank outperformed all other algorithms in accuracy, followed closely by MeSH and author rank. Our results show that the accuracy of MeSH term-based matching can be enhanced with other metadata such as author rank

    Going Beyond Counting First Authors in Author Co-citation Analysis

    No full text
    The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed

    "Closing the R&D Gap, Evaluating the Sources of R&D Spending"

    No full text
    Both spending and tax policies have been implemented in the United States with the goal of stimulating private sector research and development (R&D). Karier questions whether current R&D policy, especially the research and experimentation tax credit, can contribute to closing the gap between nondefense expenditures on R&D in the United States and such expenditures in other countries, such as Japan and Germany. He also explores possible changes to our current R&D policy to make it more effective.

    Extra-hepatic Morbidity and Mortality of Chronic Hepatitis C

    No full text
    Chronic hepatitis C virus (HCV) infection is associated with several extra-hepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its sequelae, ranging from cutaneous and visceral vasculitis to glomerulonephritis and B cell non-Hodgkin’s lymphoma. HCV-infected patients have increased rates of insulin resistance, diabetes and atherosclerosis, which may lead to increased cardiovascular morbidity and mortality. Neurologic manifestations of HCV infection include fatigue and cognitive impairment. The mechanisms causing the extra-hepatic effects of HCV infection are likely multifactorial and may include endocrine effects, HCV replication in extra-hepatic cells, or a heightened immune reaction with systemic effects. Successful eradication of HCV with interferon alpha and ribavirin was shown to improve some of these extra-hepatic effects: sustained virologic response is associated with resolution of complications of cryoglobulinemia, reduced levels of insulin resistance, reduced incidence of diabetes and stroke, and improved fatigue and cognitive functioning. The availability of new interferon-free, well-tolerated anti-HCV treatment regimens is broadening the spectrum of patients available for therapy, including those in whom interferon was contraindicated, and will likely result in greater improvements in the extra-hepatic manifestations of HCV. If these regimens are shown to confer significant benefit in the metabolic, cardiovascular, or neuropsychiatric conditions associated with HCV infection, extra-hepatic manifestations of HCV may become a major indication for treatment even in the absence of liver disease

    A. D. Fricke, author

    No full text
    Black and white photograph of author, A. D. Fricke

    Dispelling the Myths Behind First-author Citation Counts

    No full text
    We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more sophisticated methods

    Scholarly Communication and Publishing Lunch and Learn Talk #11: The ULS Open Access Author Fee Fund

    No full text
    At the May 2014 talk, you will learn about the ULS Open Access Author Fee Fund--what it is, why we do it, how it works, and how the program is going so far
    corecore